An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
- PMID: 25751583
- PMCID: PMC4900459
- DOI: 10.2174/1874473708666150309124820
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Abstract
Neuropyschological dysfunction, ranging from mild cerebral indicators to dementia has been a consistent part of the medical picture of HIV/AIDS. However, advances in medical supervision, particularly as a result of antiretroviral (ARV) treatment, have resulted in some mitigation of the neuropsychological effects of HIV and necessitate re-evaluation of the pattern and nature of HIV-related cognitive or mental deficits. The associated enhancements in morbidity and mortality that have occurred as a result of ARV medication have led to a need for interventions and programs that maintain behaviors that are healthy and stop the resurgence of the risk of HIV transmission. Risk factors such as mental illness and substance use that may have contributed to the initial infection with HIV still need consideration. These risk factors may also increase neuropsychological dysfunction and impact observance of prevention for treatment and recommendations. Explicitly, a better comprehension of the role of substance use on the progression of HIV-related mental decline can enlighten management and evaluation of persons living with HIV with concurrent disorders of substance use. This review provides a summary of the neurophyschology of substance use and HIV and the existing research that has looked at the effects of both substance use and HIV disease on neurophyscological function and suggestions for future research and treatment.
Conflict of interest statement
The authors confirm that this article content has no conflict of interest.
Similar articles
-
Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.Curr Drug Abuse Rev. 2009 May;2(2):143-56. doi: 10.2174/1874473710902020143. Curr Drug Abuse Rev. 2009. PMID: 19630745 Free PMC article. Review.
-
Mental health and substance use in HIV-infected adolescents.Curr Opin HIV AIDS. 2018 May;13(3):204-211. doi: 10.1097/COH.0000000000000451. Curr Opin HIV AIDS. 2018. PMID: 29401120 Review.
-
The Important Role of Mental Illness and Substance Abuse in Successful Management of HIV Infection.J Assoc Nurses AIDS Care. 2017 Mar-Apr;28(2):181-184. doi: 10.1016/j.jana.2017.01.002. J Assoc Nurses AIDS Care. 2017. PMID: 28236902 No abstract available.
-
Mental disorders and drug abuse in persons living with HIV/AIDS.AIDS Care. 2004;16 Suppl 1:S22-42. doi: 10.1080/09540120412331315303. AIDS Care. 2004. PMID: 15736820 Review.
-
Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.AIDS Care. 2004;16 Suppl 1:S71-96. doi: 10.1080/09540120412331315277. AIDS Care. 2004. PMID: 15736823 Review.
Cited by
-
Longitudinal changes in neurocognitive performance related to drug use intensity in a sample of persons with and without HIV who use illicit stimulants.Drug Alcohol Depend. 2023 Oct 1;251:110923. doi: 10.1016/j.drugalcdep.2023.110923. Epub 2023 Aug 9. Drug Alcohol Depend. 2023. PMID: 37598454 Free PMC article.
-
Central Nervous System Effects of COVID-19 in People with HIV Infection.Curr HIV/AIDS Rep. 2021 Dec;18(6):538-548. doi: 10.1007/s11904-021-00582-x. Epub 2021 Nov 29. Curr HIV/AIDS Rep. 2021. PMID: 34843065 Free PMC article. Review.
-
[Differential diagnostics of dementia type diseases].Radiologe. 2015 May;55(5):378-85. doi: 10.1007/s00117-014-2799-z. Radiologe. 2015. PMID: 25944275 Review. German.
-
How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?Eur Geriatr Med. 2019 Apr;10(2):227-238. doi: 10.1007/s41999-019-00164-6. Epub 2019 Jan 21. Eur Geriatr Med. 2019. PMID: 34652756
-
The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition.Viruses. 2023 Mar 3;15(3):674. doi: 10.3390/v15030674. Viruses. 2023. PMID: 36992383 Free PMC article.
References
-
- Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69–81. - PubMed
-
- McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4(9):543–55. - PubMed
-
- McArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol. 2010;67(6):699–714. - PubMed
-
- Navia B, Cho ES, Petito C, Price R. The AIDS dementia complex: II. Neuropathology Ann Neurol. 1986;19:525–35. - PubMed
-
- McArthur JC. Neurological and neuropathological manifestations of HIV infection. In: Grant I, martin A, editors. Neuropsychology of HIV infection. New York: Oxford University Press; 1994. pp. 56–107.